1-2 of 2
marginal zone b-cell lymphoma
Close
Sort by
Journal Articles

Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphoma

Clinical Trials & Observations
Panayiotis Panayiotidis, George A. Follows, Luigina Mollica, Arnon Nagler, Muhit Özcan, Armando Santoro, Don Stevens, David Trevarthen, Florian Hiemeyer, Jose Garcia-Vargas, Barrett H. Childs, Pier Luigi Zinzani, Martin Dreyling
Journal: Blood Advances
Blood Adv (2021) 5 (3): 823–828.
https://doi.org/10.1182/bloodadvances.2020002910
Published: 2021
Includes: Supplemental data
Journal Articles

Resistance mechanism for ibrutinib in marginal zone lymphoma

Clinical Trials & Observations
Narendranath Epperla, Arwa Y. Shana’ah, Dan Jones, Beth A. Christian, Sabarish Ayyappan, Kami Maddocks, Jennifer A. Woyach
Journal: Blood Advances
Blood Adv (2019) 3 (4): 500–502.
https://doi.org/10.1182/bloodadvances.2018029058
Published: 2019
Includes: Supplemental data